| Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study KA Al Sulaiman, O Aljuhani, K Eljaaly, AA Alharbi, AM Al Shabasy, ... International Journal of Infectious Diseases 105, 180-187, 2021 | 54 | 2021 |
| Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: A propensity score matched study K Al Sulaiman, O Aljuhani, KB Saleh, HA Badreldin, A Al Harthi, M Alenazi, ... Scientific reports 11 (1), 17648, 2021 | 52 | 2021 |
| Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia TA Alsulaiman, HA Al-Ajmi, SM Al-Qahtani, IM Fadlallah, NE Nawar, ... Journal of Family and Community Medicine 23 (1), 1-5, 2016 | 44 | 2016 |
| Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case–control study FAS Aleidan, H Alkhelaifi, A Alsenaid, H Alromaizan, F Alsalham, ... Expert Review of Anti-infective Therapy 19 (3), 393-398, 2021 | 41 | 2021 |
| Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study K Al Sulaiman, O Aljuhani, M Al Dossari, A Alshahrani, A Alharbi, ... Critical Care 25, 1-8, 2021 | 35 | 2021 |
| Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study K Al Sulaiman, O Aljuhani, AI Al Shaya, A Kharbosh, R Kensara, ... Critical Care 25, 1-8, 2021 | 35 | 2021 |
| Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study K Al Sulaiman, GB Korayem, AF Altebainawi, S Al Harbi, A Alissa, ... Critical Care 26 (1), 304, 2022 | 25 | 2022 |
| Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study K Al Sulaiman, HA Badreldin, GB Korayem, AA Alenazi, F Alsuwayyid, ... Thrombosis Journal 20 (1), 25, 2022 | 12 | 2022 |
| The role of inhaled corticosteroids (ICS) in critically Ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, K Al Aamer, O Al Shaya, A Al Shaya, ... Journal of Intensive Care Medicine 37 (2), 248-257, 2022 | 12 | 2022 |
| The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study K Al Sulaiman, O Aljuhani, HA Badreldin, GB Korayem, AA Alenazi, ... BMC infectious diseases 23 (1), 75, 2023 | 8 | 2023 |
| Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study O Aljuhani, K Al Sulaiman, A Alshabasy, K Eljaaly, AI Al Shaya, ... BMC Infectious Diseases 21, 1-8, 2021 | 8 | 2021 |
| Evaluation of low-dose aspirin use among critically Ill patients with COVID-19: A multicenter propensity score matched study AF Al Harthi, O Aljuhani, GB Korayem, AF Altebainawi, RS Alenezi, ... Journal of Intensive Care Medicine 37 (9), 1238-1249, 2022 | 7 | 2022 |
| Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study O Aljuhani, K Al Sulaiman, A Hafiz, K Eljaaly, A Alharbi, R Algarni, ... Saudi Pharmaceutical Journal 30 (4), 398-406, 2022 | 7 | 2022 |
| Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study K Al Sulaiman, O Aljuhani, KB Salah, GB Korayem, K Eljaaly, M Al Essa, ... Journal of Critical Care 66, 44-51, 2021 | 7 | 2021 |
| Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz, M Alalawi, HA Badreldin, ... Thrombosis Journal 20 (1), 74, 2022 | 6 | 2022 |
| The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study GB Korayem, O Aljuhani, AF Altebainawi, AI Al Shaya, LI Alnajjar, A Alissa, ... International Journal of Infectious Diseases 122, 252-259, 2022 | 6 | 2022 |
| The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, GB Korayem, AF Altebainawi, S Al Harbi, ... Frontiers in Public Health 10, 877944, 2022 | 6 | 2022 |
| Vitamin D serum level predicts stroke clinical severity, functional independence, and disability—A retrospective cohort study AR Alharbi, AS Alali, Y Samman, NA Alghamdi, O Albaradie, ... Frontiers in Neuroscience 16, 951283, 2022 | 6 | 2022 |
| The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study KA Sulaiman, N Al Qahtani, M Al Muqrin, M Al Dossari, A Al Wabel, ... Journal of International Medical Research 50 (7), 03000605221108082, 2022 | 6 | 2022 |
| Statins and risk of thrombosis in critically ill patients with COVID-19: a multicenter cohort study S Al Harbi, R Kensara, O Aljuhani, GB Korayem, AF Altebainawi, ... Clinical and Applied Thrombosis/Hemostasis 28, 10760296221103864, 2022 | 6 | 2022 |
Ramesh Kumar VishwakarmaResearch Biostatistician在 ngha.med.sa 的电子邮件经过验证
Ramesh Kumar VishwakarmaResearch Biostatistician在 ngha.med.sa 的电子邮件经过验证